Logo image of CMRC

COMMERCE.COM INC (CMRC) Stock Fundamental Analysis

USA - NASDAQ:CMRC - US08975P1084 - Common Stock

4.95 USD
+0.1 (+2.06%)
Last: 10/21/2025, 8:06:12 PM
4.98 USD
+0.03 (+0.61%)
After Hours: 10/21/2025, 8:06:12 PM
Fundamental Rating

3

Overall CMRC gets a fundamental rating of 3 out of 10. We evaluated CMRC against 86 industry peers in the IT Services industry. The financial health of CMRC is average, but there are quite some concerns on its profitability. CMRC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CMRC had positive earnings in the past year.
In the past year CMRC had a positive cash flow from operations.
CMRC had negative earnings in each of the past 5 years.
In the past 5 years CMRC reported 4 times negative operating cash flow.
CMRC Yearly Net Income VS EBIT VS OCF VS FCFCMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

CMRC's Return On Assets of -5.99% is on the low side compared to the rest of the industry. CMRC is outperformed by 70.93% of its industry peers.
CMRC's Return On Equity of -46.74% is on the low side compared to the rest of the industry. CMRC is outperformed by 76.74% of its industry peers.
Industry RankSector Rank
ROA -5.99%
ROE -46.74%
ROIC N/A
ROA(3y)-17.34%
ROA(5y)-15.95%
ROE(3y)-213.47%
ROE(5y)-142.73%
ROIC(3y)N/A
ROIC(5y)N/A
CMRC Yearly ROA, ROE, ROICCMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

With an excellent Gross Margin value of 78.06%, CMRC belongs to the best of the industry, outperforming 96.51% of the companies in the same industry.
In the last couple of years the Gross Margin of CMRC has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CMRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
CMRC Yearly Profit, Operating, Gross MarginsCMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

CMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
CMRC has more shares outstanding than it did 1 year ago.
CMRC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CMRC has an improved debt to assets ratio.
CMRC Yearly Shares OutstandingCMRC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CMRC Yearly Total Debt VS Total AssetsCMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

CMRC has an Altman-Z score of -0.60. This is a bad value and indicates that CMRC is not financially healthy and even has some risk of bankruptcy.
CMRC has a Altman-Z score of -0.60. This is amonst the worse of the industry: CMRC underperforms 82.56% of its industry peers.
CMRC has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CMRC would need 6.27 years to pay back of all of its debts.
CMRC has a Debt to FCF ratio (6.27) which is in line with its industry peers.
CMRC has a Debt/Equity ratio of 4.06. This is a high value indicating a heavy dependency on external financing.
CMRC has a Debt to Equity ratio of 4.06. This is amonst the worse of the industry: CMRC underperforms 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 6.27
Altman-Z -0.6
ROIC/WACCN/A
WACC7.23%
CMRC Yearly LT Debt VS Equity VS FCFCMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CMRC has a Current Ratio of 2.13. This indicates that CMRC is financially healthy and has no problem in meeting its short term obligations.
CMRC's Current ratio of 2.13 is fine compared to the rest of the industry. CMRC outperforms 61.63% of its industry peers.
CMRC has a Quick Ratio of 2.13. This indicates that CMRC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CMRC (2.13) is better than 62.79% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
CMRC Yearly Current Assets VS Current LiabilitesCMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

CMRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
CMRC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.05%.
The Revenue has been growing by 24.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)4.05%
Revenue growth 3Y14.83%
Revenue growth 5Y24.32%
Sales Q2Q%3.18%

3.2 Future

CMRC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.37% yearly.
Based on estimates for the next years, CMRC will show a small growth in Revenue. The Revenue will grow by 4.71% on average per year.
EPS Next Y-23.9%
EPS Next 2Y5.22%
EPS Next 3Y14.37%
EPS Next 5YN/A
Revenue Next Year3.24%
Revenue Next 2Y3.95%
Revenue Next 3Y4.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CMRC Yearly Revenue VS EstimatesCMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CMRC Yearly EPS VS EstimatesCMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.68 indicates a rather expensive valuation of CMRC.
Based on the Price/Earnings ratio, CMRC is valued a bit cheaper than the industry average as 73.26% of the companies are valued more expensively.
CMRC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
CMRC is valuated correctly with a Price/Forward Earnings ratio of 15.97.
Based on the Price/Forward Earnings ratio, CMRC is valued a bit cheaper than 72.09% of the companies in the same industry.
CMRC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.68
Fwd PE 15.97
CMRC Price Earnings VS Forward Price EarningsCMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMRC indicates a slightly more expensive valuation: CMRC is more expensive than 69.77% of the companies listed in the same industry.
CMRC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CMRC is cheaper than 73.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.91
EV/EBITDA 220.69
CMRC Per share dataCMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

CMRC's earnings are expected to grow with 14.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.22%
EPS Next 3Y14.37%

0

5. Dividend

5.1 Amount

CMRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COMMERCE.COM INC

NASDAQ:CMRC (10/21/2025, 8:06:12 PM)

After market: 4.98 +0.03 (+0.61%)

4.95

+0.1 (+2.06%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners70.06%
Inst Owner ChangeN/A
Ins Owners10.48%
Ins Owner Change7.18%
Market Cap399.66M
Revenue(TTM)337.54M
Net Income(TTM)-18118000
Analysts70
Price Target7.48 (51.11%)
Short Float %8.14%
Short Ratio6.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.46%
Min EPS beat(2)15%
Max EPS beat(2)29.93%
EPS beat(4)4
Avg EPS beat(4)68.16%
Min EPS beat(4)15%
Max EPS beat(4)168.48%
EPS beat(8)8
Avg EPS beat(8)76.94%
EPS beat(12)12
Avg EPS beat(12)68.23%
EPS beat(16)14
Avg EPS beat(16)54.08%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.04%
Max Revenue beat(2)-0.64%
Revenue beat(4)0
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-2.04%
Max Revenue beat(4)-0.64%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)4
Avg Revenue beat(12)-0.63%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-8.62%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.68
Fwd PE 15.97
P/S 1.18
P/FCF 15.91
P/OCF 12.53
P/B 10.31
P/tB N/A
EV/EBITDA 220.69
EPS(TTM)0.28
EY5.66%
EPS(NY)0.31
Fwd EY6.26%
FCF(TTM)0.31
FCFY6.29%
OCF(TTM)0.39
OCFY7.98%
SpS4.18
BVpS0.48
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.74
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -46.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.06%
FCFM 7.44%
ROA(3y)-17.34%
ROA(5y)-15.95%
ROE(3y)-213.47%
ROE(5y)-142.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 6.27
Debt/EBITDA 103.92
Cap/Depr 45.32%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion 2103.63%
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z -0.6
F-Score6
WACC7.23%
ROIC/WACCN/A
Cap/Depr(3y)35.32%
Cap/Depr(5y)44.65%
Cap/Sales(3y)1.44%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-23.9%
EPS Next 2Y5.22%
EPS Next 3Y14.37%
EPS Next 5YN/A
Revenue 1Y (TTM)4.05%
Revenue growth 3Y14.83%
Revenue growth 5Y24.32%
Sales Q2Q%3.18%
Revenue Next Year3.24%
Revenue Next 2Y3.95%
Revenue Next 3Y4.71%
Revenue Next 5YN/A
EBIT growth 1Y65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.8%
EBIT Next 3Y46.98%
EBIT Next 5YN/A
FCF growth 1Y139.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y153.52%
OCF growth 3YN/A
OCF growth 5YN/A